Award recordCONTRACT

GRIFOLS THERAPEUTICS LLC

PIID VA25016F3033· VHA· 515-BATTLE CREEK(00515)· 6505 · DRUGS AND BIOLOGICALS· FY2017· $162,548 net obligations· UEI UFQ3A7GKJ5C7· NC

Description

PROLASTIN

First action · last action
2016-10-01 · 2017-10-19
Transactions
4
First transaction's obligation
$121,693
Base + all options value (sum of deltas)
$162,548
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30042
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$164,693$0Base award · 2016-10-01 · this action $121,693 · running total $121,693Modification P00001 · 2017-03-27 · this action $33,000 · running total $154,693Modification P00002 · 2017-08-23 · this action $10,000 · running total $164,693Modification P00003 · 2017-10-19 · this action -$2,145 · running total $162,548
  • Base2016-10-01+$121,693= $121,693
  • Mod P000012017-03-27+$33,000= $154,693
  • Mod P000022017-08-23+$10,000= $164,693
  • Mod P000032017-10-19-$2,145= $162,548
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-10-01+$121,693$121,693PROLASTIN
Mod P00001· FUNDING ONLY ACTION2017-03-27+$33,000$154,693PROLASTIN
Mod P00002· FUNDING ONLY ACTION2017-08-23+$10,000$164,693PROLASTIN
Mod P00003· CLOSE OUT2017-10-19−$2,145$162,548PROLASTIN

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI UFQ3A7GKJ5C7)

AwardOffice · PSC / listingNet obligationsFY
36C26022F0140260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$100,282FY2022
36C26022F0004260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$454,461FY2022
36C26021F0264260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$130,406FY2021
36C26021F0117260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$75,000FY2021
36C26021F0014260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$220,000FY2021
36C26021F0021260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$355,273FY2021

Other recipients under 6505 from 515-BATTLE CREEK(00515) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25018F0348SANOFI VACCINES US INC.515-BATTLE CREEK(00515)$107,000FY2018
36C25018F0121PFIZER INC515-BATTLE CREEK(00515)$14,554FY2018
VA25017P3158AKAAL ORGANICS, LLC515-BATTLE CREEK(00515)$16,200FY2017
VA25017J2734TRAVERE THERAPEUTICS, INC.515-BATTLE CREEK(00515)$27,468FY2017
VA25017F2705CSL BEHRING L.L.C.515-BATTLE CREEK(00515)$5,180FY2017

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25016F3033_3600_V797D30042_3600 · retrieved 2026-09-26.